Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TELO2-interacting protein 2 (TTI2) is a regulatory protein encoded by the human TTI2 gene, conserved across species and essential for the DNA damage response. As part of the Triple T (TTT) complex, TTI2 regulates the stability and folding of phosphoinositide-3-kinase-related protein kinases (PIKKs), including ATM and TOR. These actions contribute to cell resistance against DNA damage and the maintenance of cell cycle checkpoints. Mutations in TTI2 lead to significant neurodevelopmental disorders, highlighting its importance in brain development and cellular homeostasis. Structural studies reveal that TTI2 forms elongated helical repeats facilitating the proper recruitment of PIKKs to chaperone systems such as R2TP and HSP90, linking protein quality control with DDR signaling[1][2][4][6].
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TELO2-interacting protein 2 (TTI2).